• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effects of CFTR modulator therapies on liver stiffness and bile flow: A single-centre experience.

作者信息

Calvo Pier Luigi, Giugliano Laura, Evangelista Andrea, Bignamini Elisabetta, Pinon Michele

机构信息

Pediatric Gastroenterology Unit, Regina Margherita Children's Hospital, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Turin, Italy.

Pediatric Gastroenterology Unit, Regina Margherita Children's Hospital, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Turin, Italy.

出版信息

J Hepatol. 2023 Aug;79(2):e76-e78. doi: 10.1016/j.jhep.2023.02.006. Epub 2023 Feb 17.

DOI:10.1016/j.jhep.2023.02.006
PMID:36804403
Abstract
摘要

相似文献

1
Effects of CFTR modulator therapies on liver stiffness and bile flow: A single-centre experience.囊性纤维化跨膜传导调节因子（CFTR）调节剂疗法对肝脏硬度和胆汁流动的影响：单中心经验
J Hepatol. 2023 Aug;79(2):e76-e78. doi: 10.1016/j.jhep.2023.02.006. Epub 2023 Feb 17.
2
Reply to: "The effects of CFTR modulator therapies on liver stiffness and bile flow: A single-centre experience".
J Hepatol. 2023 Aug;79(2):e78-e80. doi: 10.1016/j.jhep.2023.04.001. Epub 2023 Apr 10.
3
Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.熊去氧胆酸可独立于囊性纤维化跨膜转导调节因子 (Cftr) 调节胆汁流量和胆汁盐池在小鼠中。
Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G1035-42. doi: 10.1152/ajpgi.00258.2011. Epub 2012 Feb 2.
4
Increase of liver stiffness and altered bile acid metabolism after triple CFTR modulator initiation in children and young adults with cystic fibrosis.三联 CFTR 调节剂治疗启动后儿童和青年囊性纤维化患者肝硬度增加和胆汁酸代谢改变。
Liver Int. 2023 Apr;43(4):878-887. doi: 10.1111/liv.15544. Epub 2023 Feb 28.
5
Prenatal Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Promising Way to Change the Impact of Cystic Fibrosis.产前囊性纤维化跨膜电导调节剂调节剂治疗：改变囊性纤维化影响的一种有前途的方法。
Fetal Diagn Ther. 2023;50(2):136-142. doi: 10.1159/000530261. Epub 2023 Mar 30.
6
Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice.过氧化物酶体增殖物激活受体α减少与囊性纤维化跨膜传导调节因子基因敲除小鼠的胆管损伤有关。
J Pediatr Gastroenterol Nutr. 2006 Mar;42(3):275-81. doi: 10.1097/01.mpg.0000189368.37535.42.
7
Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.囊性纤维化跨膜传导调节因子在囊性纤维化患者肝脏组织中的表达。
Hepatology. 2000 Aug;32(2):334-40. doi: 10.1053/jhep.2000.9111.
8
Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.将囊性纤维化跨膜电导调节剂功能与临床特征相关联，以指导囊性纤维化的精准治疗。
Am J Respir Crit Care Med. 2019 May 1;199(9):1116-1126. doi: 10.1164/rccm.201901-0145OC.
9
Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells.囊性纤维化跨膜传导调节因子在人胆管上皮细胞中的定位
Gastroenterology. 1993 Dec;105(6):1857-64. doi: 10.1016/0016-5085(93)91085-v.
10
Elevated Levels of Toxic Bile Acids in Serum of Cystic Fibrosis Patients with Mutations Causing Pancreatic Insufficiency.囊性纤维化伴胰腺功能不全突变患者血清中毒性胆酸水平升高。
Int J Mol Sci. 2022 Oct 18;23(20):12436. doi: 10.3390/ijms232012436.

引用本文的文献

1
Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era.囊性纤维化中不断发展的营养治疗：适应CFTR调节剂时代。
Nutr Clin Pract. 2025 Aug;40(4):816-828. doi: 10.1002/ncp.11332. Epub 2025 Jun 18.
2
The effect of elexacaftor-tezacaftor-ivacaftor on liver stiffness in children with cystic fibrosis.依列卡托-替扎卡托-依伐卡托对囊性纤维化儿童肝脏硬度的影响。
J Pediatr Gastroenterol Nutr. 2025 Jul;81(1):74-81. doi: 10.1002/jpn3.70050. Epub 2025 Apr 23.
3
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.
囊性纤维化肝胆道疾病筛查、评估和管理的共识建议。
Hepatology. 2024 May 1;79(5):1220-1238. doi: 10.1097/HEP.0000000000000646. Epub 2023 Oct 26.